Efficacy of olanzapine augmentation of paroxetine therapy in patients with severe body dysmorphic disorder.
Nakaaki
Shutaro
S
Murata
Yoshie
Y
Furukawa
Toshi A
TA
D000328:Adult; D018687:Antidepressive Agents, Second-Generation / Q000008:administration & dosage*; D014150:Antipsychotic Agents / Q000008:administration & dosage*; D001569:Benzodiazepines / Q000009:adverse effects*; D001828:Body Image; D003702:Delusions / Q000188:drug therapy* / Q000523:psychology; D004305:Dose-Response Relationship, Drug; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D009771:Obsessive-Compulsive Disorder / Q000188:drug therapy* / Q000523:psychology; D000077152:Olanzapine; D017374:Paroxetine / Q000008:administration & dosage*
D018687:Antidepressive Agents, Second-Generation; D014150:Antipsychotic Agents; D001569:Benzodiazepines; D017374:Paroxetine; D000077152:Olanzapine